MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-191

  1. 3,795 Posts.
    lightbulb Created with Sketch. 359
    end points met. You and your friends bang on that with other completed phase 3 MSB trials.

    ohhh, hang on, there is another hurdle. ‘FDA don’t fully understand how it works’ But it’s shown it works - p values tick, what was % survival, over 60%!!

    Doc, You have a case for the other products but seriously, this one, nope! Just admit your not invested in MSB it’s all banter or whatever else you may call it!

    at least you’re having fun!

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.